Linagliptin + metformin

Trade Name: 
Jentadueto
Manufacturer/Distributor: 
Boehringer Ingelheim
www.boehringer-ingelheim.ca
Classification: 
Oral antihyperglycemic agent
DPP-4 inhibitor
Incretin enhancer
ATC Class: 
A10BD11 - metformin and linagliptin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2013/03/07
Date Marketed in Canada (yyyy/mm/dd): 
2013/04/17
Presentation: 
Tablet: 2.5 mg linagliptin + 500 mg metformin. DIN: 02403250
Tablet: 2.5 mg linagliptin + 850 mg metformin. DIN: 02403269
Tablet: 2.5 mg linagliptin + 1000 mg metformin. DIN: 02403277
Comments: 
Indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate, in patients inadequately controlled on metformin alone or in patients already being treated and well controlled with the free combination of linagliptin and metformin.